This collaboration marks a significant milestone in the fields of clinical immunology and cell biology. It aims to strengthen research capabilities, promote knowledge exchange, and accelerate talent development across both institutions. Under this MoU, CTSCB and WEHI will jointly explore diverse business opportunities and potential research collaborations, with a focus on pioneering medical research in immunology and cell biology.

July 28 - Led by Professor Pengtao Liu, the CTSCB team won the gold medal for the innovative project “A Novel Stem Cell-Based Technology for Anti-viral Discovery and Health Natural Products.” The technology introduces a human EPSC-derived trophoblast model, which serves as an ideal system for virology research of diverse viruses and the discovery of potentially broad-spectrum antivirals.

The centre also captured a second gold medal for the pioneering project “A Novel Cellular System for Anti-ageing Drug Discovery.” The invention introduces an ageing-emulated biosystem derived from human trophoblast stem cells. The biosystem displays major ageing hallmarks and establishes an accelerated ageing model. This robust tool holds promise for advancing the understanding of ageing, expediting the development of anti-ageing, and improving human health and longevity.

In addition to the two gold medals, the CTSCB team secured a silver medal for the project” A New Stem Cell Platform for personalized treatment and drug discovery for primary immunodeficiency patients.”, which enables personalized treatment selection and new drug screening.

CTSCB will continue to transform our novel stem cell research innovations into real-world applications.

CTSCB wins two gold medals and one silver at this year's Silicon Valley International Inventions Festival.

Photo showed Dr. RUAN Degong receives the gold medal.

May 16 - CTSCB and AstraZeneca signed a Memorandum of Understanding (MoU) at the Asia Summit on Global Health.  The ceremony was officiated by Professor Pengtao Liu (Managing Director, CTSCB) and Ms. Elise Ho (Business Unit Director, RIG, Macau and Alliance, AstraZeneca).

The signing of the MoU was witnessed by Mr. Lee Kwok Bun Ivan, JP, Commissioner for Innovation and Technology (ITC), Dr. Patrick Lau, Deputy Executive Director of the Hong Kong Trade Development Council (HKTDC), along with Professor Gordon Dougan (Co-director, CTSCB), Professor Chak-sing Lau (Dean of Medicine, HKU and Programme Leader, CTSCB), Professor Fang Liu (Senior Scientific Director, CTSCB) and Ms. Shan Wu (General Manager, AstraZeneca Hong Kong and Macau).

This MoU solidifies the long-standing partnership between CTSCB and AstraZeneca, and provides a framework for continued collaboration to foster innovation in stem cell translational clinical application.

Photo shows the Commissioner for Innovation and Technology, Mr. Lee Kwok Bun Ivan, JP, (second row, 3^rd right), Deputy Executive Director of the Hong Kong Trade Development Council, Dr. Patrick Lau (second row, 2^nd right) with Professor Pengtao Liu (front row, right), Ms. Elise Ho (front row, left), Professor Gordon Dougan (second row, 1^st right), Professor Chak-sing Lau (second row, 2^nd left), Professor Fang Liu (second row, 1^st left) and Ms. Shan Wu (second row, 3^rd left) at the Mou Signing Ceremony.

Commissioner for Innovation and Technology, Mr. Lee Kwok Bun Ivan, JP and Deputy Executive Director of the Hong Kong Trade Development Council, Dr. Patrick Lau visit our booth at the Asia Summit on Global Health.

The signing ceremony was officiated by Professor Pengtao Liu (Managing Director, CTSCB), Professor Gordon Dougan (Co-director, CTSCB), and Mr. Vincent Lin (Director of BD center, MGI).

This collaboration between CTSCB and MGI marks an exciting milestone in the advancement of single cell technology. By combining MGI's cutting-edge sequencing platforms with the expertise of the CTSCB in stem cell research, the strategic partnership is poised to unlock new insights into cell identity, cellular heterogeneity and disease mechanisms.

“Together, we aim to revolutionize the field of single cell genomics and drive scientific discoveries that will ultimately improve human health,” said Professor Pengtao Liu.

Photo shows Professor Pengtao Liu (front row, Left), Mr. Vincent Lam (front row, right), Professor Gordon Dougan (second row, 3rd right) with representatives from MGI